Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Initiation of phase IV trial of Periostat and Atridox combination therapy

Jan. 9, 2003

Expanded indication for EmdogainGel in E.U.

Nov. 27, 2002

Atridox to be studied in chronic periodontitis/heart disease trial

July 16, 2002

FDA approves pivotal periodontal surgery trial of dermal substitute

July 11, 2002

Selective Lys-gingipain inhibitors for use in periodontitis

July 3, 2002

Periostat receives final marketing approvals in Portugal and The Netherlands

July 2, 2002

Platelet-derived growth factor evaluated in periodontal disease

May 31, 2002

Periostat approved in Israel

May 8, 2002

Periostat approved in Austria and Finland

April 26, 2002

MMP inhibitors with activity in animal model of periodontitis

April 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...